GSK is to further advance its commitment towards transparency, openness and collaboration, as these attributes are essential to finding new drugs to treat global diseases, according to CEO Sir ...

This model aims to provide a more transparent and predictable drug pricing structure. It addresses the complexities and ...

The U.S. government said on Wednesday it will aim for "greater transparency" in Medicare drug price negotiations under ...